BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33113627)

  • 1. [Value of ultrasound-targeted vascular endothelial growth factor receptor-2 in non-invasive monitoring of anti-angiogenic response in nude mice with subcutaneous xenograft model].
    Wang L; Lu YH; Wang TY
    Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):856-860. PubMed ID: 33113627
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of low-frequency ultrasound and microbubbles on angiogenesis-associated proteins in subcutaneous tumors of nude mice.
    Shen ZY; Shen E; Zhang JZ; Bai WK; Wang Y; Yang SL; Nan SL; Lin YD; Li Y; Hu B
    Oncol Rep; 2013 Aug; 30(2):842-50. PubMed ID: 23707983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced Ultrasound in evaluating of angiogenesis and tumor staging of nasopharyngeal carcinoma in nude mice.
    Liang S; Gao Y; Liu Y; Qiu C; Chen Y; Zhu S
    PLoS One; 2019; 14(8):e0221638. PubMed ID: 31442259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-Targeted Microbubbles Specific to Integrin αVβ3 and Vascular Endothelial Growth Factor Receptor 2 for Ultrasonography Evaluation of Tumor Angiogenesis.
    Yuan HX; Wang WP; Wen JX; Lin LW; Exner AA; Guan PS; Chen XJ
    Ultrasound Med Biol; 2018 Jul; 44(7):1460-1467. PubMed ID: 29706409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of VEGFR-2 targeted ultrasound contrast agent for the early evaluation of response to sorafenib in a mouse model of hepatocellular carcinoma.
    Baron Toaldo M; Salvatore V; Marinelli S; Palamà C; Milazzo M; Croci L; Venerandi L; Cipone M; Bolondi L; Piscaglia F
    Mol Imaging Biol; 2015 Feb; 17(1):29-37. PubMed ID: 25082536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced ultrasound with perflubutane in the assessment of anti-angiogenic effects: early prediction of the anticancer activity of bevacizumab in a mouse xenografted model.
    Watanabe R; Munemasa T; Matsumura M
    Ultrasound Med Biol; 2015 Sep; 41(9):2497-505. PubMed ID: 26022792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring Dual VEGF Inhibition in Human Pancreatic Tumor Xenografts With Dynamic Contrast-Enhanced Ultrasound.
    Lamuraglia M; Barrois G; Le Guillou-Buffello D; Santin M; Kerbol A; Comperat E; Coron A; Lucidarme O; Bridal SL
    Technol Cancer Res Treat; 2020; 19():1533033819886896. PubMed ID: 32065066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular ultrasound imaging using a targeted contrast agent for assessing early tumor response to antiangiogenic therapy.
    Sorace AG; Saini R; Mahoney M; Hoyt K
    J Ultrasound Med; 2012 Oct; 31(10):1543-50. PubMed ID: 23011617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis.
    Rychak JJ; Graba J; Cheung AM; Mystry BS; Lindner JR; Kerbel RS; Foster FS
    Mol Imaging; 2007; 6(5):289-96. PubMed ID: 18092513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic Modeling of Targeted Ultrasound Contrast Agents for Quantitative Assessment of Anti-Angiogenic Therapy: a Longitudinal Case-Control Study in Colon Cancer.
    Turco S; El Kaffas A; Zhou J; Lutz AM; Wijkstra H; Willmann JK; Mischi M
    Mol Imaging Biol; 2019 Aug; 21(4):633-643. PubMed ID: 30225758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted contrast-enhanced ultrasound imaging of angiogenesis in an orthotopic mouse tumor model of renal carcinoma.
    Wei S; Fu N; Sun Y; Yang Z; Lei L; Huang P; Yang B
    Ultrasound Med Biol; 2014 Jun; 40(6):1250-9. PubMed ID: 24613557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regions of interest and parameters for the quantitative analysis of contrast-enhanced ultrasound to evaluate the anti-angiogenic effects of bevacizumab.
    Zhang HP; Shi QS; Li F; Liu L; Bai M; Gu JY; Wu Y; Du LF
    Mol Med Rep; 2013 Jul; 8(1):154-60. PubMed ID: 23722237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification in molecular ultrasound imaging: a comparative study in mice between healthy liver and a human hepatocellular carcinoma xenograft.
    Sugimoto K; Moriyasu F; Negishi Y; Hamano N; Oshiro H; Rognin NG; Yoshida T; Kamiyama N; Aramaki Y; Imai Y
    J Ultrasound Med; 2012 Dec; 31(12):1909-16. PubMed ID: 23197543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive contrast-enhanced US quantitative assessment of tumor microcirculation in a murine model: effect of discontinuing anti-VEGF therapy.
    Guibal A; Taillade L; Mulé S; Comperat E; Badachi Y; Golmard JL; Le Guillou-Buffello D; Rixe O; Bridal SL; Lucidarme O
    Radiology; 2010 Feb; 254(2):420-9. PubMed ID: 20093514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts.
    Jia WD; Xu GL; Xu RN; Sun HC; Wang L; Yu JH; Wang J; Li JS; Zhai ZM; Xue Q
    J Cancer Res Clin Oncol; 2003 Jun; 129(6):327-34. PubMed ID: 12811549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound-targeted microbubble destruction improved the antiangiogenic effect of Endostar in triple-negative breast carcinoma xenografts.
    Jing Y; Xiu-Juan Z; Hong-Jiao C; Zhi-Kui C; Qing-Fu Q; En-Sheng X; Li-Wu L
    J Cancer Res Clin Oncol; 2019 May; 145(5):1191-1200. PubMed ID: 30805775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-angiogenesis effect of arsenic trioxide plus cinobufacin on human hepatocarcinoma transplantation model nude mice].
    Liu L; Chen BA; Qin SK
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Jan; 31(1):67-72. PubMed ID: 21434348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.
    Mancini M; Greco A; Salvatore G; Liuzzi R; Di Maro G; Vergara E; Chiappetta G; Pasquinelli R; Brunetti A; Salvatore M
    BMC Med Imaging; 2013 Sep; 13():31. PubMed ID: 24028408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the impact of transient interruption of antiangiogenic treatment using ultrasound-based techniques in a murine model of hepatocellular carcinoma.
    Marinelli S; Salvatore V; Baron Toaldo M; Milazzo M; Croci L; Venerandi L; Pecorelli A; Palamà C; Diana A; Bolondi L; Piscaglia F
    BMC Cancer; 2014 Jun; 14():403. PubMed ID: 24902850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring angiogenesis in human melanoma xenograft model using contrast-enhanced ultrasound imaging.
    Forsberg F; Ro RJ; Liu JB; Lipcan KJ; Potoczek M; Nazarian LN
    Ultrason Imaging; 2008 Oct; 30(4):237-46. PubMed ID: 19507677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.